Timeliness of review and approval of new drugs in Canada from 1999 through 2001: Is progress being made?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Timeliness of review and approval of new drugs in Canada from 1999 through 2001: Is progress being made?

Published:2003-04 Issue:4 Volume:25 Page:1230-1247
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Rawson Nigel S.B.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference46 articles.

1. Comparison of the drug approval processes in the US, the EU and Canada;Paul;Int J Med Marketing,2001

2. Report of the Commission of Inquiry on the Pharmaceutical Industry;Eastman,1985

3. Health and Sports Program: A Study Team Report to the Task Force on Program Review;Nielsen Task Force,1985

4. Drug Regulation. Report of the Auditor General of Canada to the House of Commons, Fiscal Year Ending 31 March 1987,1987

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The timelines for the price and reimbursement authorization in Italy 2018–2020;Frontiers in Medicine;2022-12-21

2. Canadian, European and United States new drug approval times now relatively similar;Regulatory Toxicology and Pharmacology;2018-07

3. REGULATORY REQUIREMENTS FOR APPROVAL OF OVER THE COUNTER DRUGS AS PER AUSTRAILIAN (TGA) GUIDELINES;INDO AM J PHARM SCI;2018

4. Health Canada's use of priority review status for drugs for unmet needs;Regulatory Toxicology and Pharmacology;2015-10

5. Priority review drugs approved by the FDA and the EMA: time for international regulatory harmonization of pharmaceuticals?;Pharmacoepidemiology and Drug Safety;2015-05-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP